Money Magnet Immunocore kicks off Trial for Eye Melanoma
Immunocore (UK) has enrolled its first patient for a phase I trial that will test…
31/03/2016 - 2 minutes
Immunocore
The Only Real European Biotech Unicorns in 2016
Unicorns are private fast-growing companies valued more than a billion euro/dollars. This club is getting…
16/02/2016 - 3 minutes
This Potential First in Class Cancer Therapy Could Help Patients Avoid Eye Surgery
Immunocore in Oxford (UK) has been Granted Orphan Drug Designation for a Phase I Super rare Eye…
25/01/2016 - 2 minutes
10 Hot European Biotechs to watch in 2016
Looking forward to 2016, I wondered which Biotechs I would watch closely. Here's my list…
12/01/2016 - 6 minutes
3 EU Biotechs which Over-performed in 2015
2015 was a crazy year for the Biotech industry, probably the craziest since the birth…
30/12/2015 - 2 minutes
Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round
Last Thursday at Genesis in London, I had the chance to meet with Eva-Lotta Allan, CBO…
21/12/2015 - 5 minutes
Infographic: The Anatomy of European Biotech
Which part of our body do European biotechs prefer to target? And how diversified are…
10/12/2015 - 1 minute
The 9 EU-based Billion-Euro Biotechs you Should (really) Know
Update 22/10/2015: I added Galapagos from Belgium and Basilea from Switzerland, they deserved it ...…
15/09/2015 - 6 minutes
It’s raining cash, Woodford invested more than 75% of its mega €1.1Bn Biotech fund
Cash is floating into Biotech like never before, in the US as well as in…
14/08/2015 - 2 minutes
Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors
Adaptimmune Therapeutics, an oxford-based company focusing on the use of T-cell therapies to treat cancer,…
22/07/2015 - 3 minutes
Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever
Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private…
16/07/2015 - 3 minutes
Lilly Cooperates with Immunocore to Fight Skin Cancer
Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based…
03/07/2015 - 2 minutes
